title: Sensory and sensorimotor gating deficits after neonatal ventral hippocampal lesions in rats.
abstract: Neonatal ventral hippocampal lesions (NVHLs) in rats lead to reduced prepulse inhibition (PPI) of startle and other behavioral deficits in adulthood that model abnormalities in schizophrenia patients. A neurophysiological deficit in schizophrenia patients and their first-degree relatives is reduced gating of the P50 event-related potential (ERP). N40 ERP gating in rats may be a cross-species analog of P50 gating, and is disrupted in experimental manipulations related to schizophrenia. Here, we tested whether N40 gating as well as PPI is disrupted after NVHLs, using contemporaneous measures of these two conceptually related phenomena. Male rat pups received sham or ibotenic acid NVHLs on postnatal day 7. PPI was tested on days 35 and 56, after which rats were equipped with cortical surface electrodes for ERP measurements. One week later, PPI and N40 gating were measured in a single test, using paired S1-S2 clicks spaced 500 ms apart to elicit N40 gating. Compared to sham-lesioned rats, those with NVHLs exhibited PPI deficits on days 35 and 56. NVHL rats also exhibited reduced N40 gating and reduced PPI, when measured contemporaneously at day 65. Deficits in PPI and N40 gating appeared most pronounced in rats with larger lesions, focused within the ventral hippocampus. In this first report of contemporaneous measures of two important schizophrenia-related phenotypes in NVHL rats, NVHLs reproduce both sensory (N40) and sensorimotor (PPI) gating deficits exhibited in schizophrenia. In this study, lesion effects were detected prior to pubertal onset, and were sustained well into adulthood.
authors.affiliation: Department of Psychiatry, University of California, San Diego, La Jolla, CA 92093, USA. nswerdlow@ucsd.edu
authors.forename: Neal R
authors.initials: NR
authors.lastname: Swerdlow
authors.forename: Gregory A
authors.initials: GA
authors.lastname: Light
authors.forename: Michelle R
authors.initials: MR
authors.lastname: Breier
authors.forename: Jody M
authors.initials: JM
authors.lastname: Shoemaker
authors.forename: Richard L
authors.initials: RL
authors.lastname: Saint Marie
authors.forename: Alaina C
authors.initials: AC
authors.lastname: Neary
authors.forename: Mark A
authors.initials: MA
authors.lastname: Geyer
authors.forename: Karen E
authors.initials: KE
authors.lastname: Stevens
authors.forename: Susan B
authors.initials: SB
authors.lastname: Powell
mesh_terms: D000161:Acoustic Stimulation; D000818:Animals; D000831:Animals, Newborn; D001930:Brain Injuries / Q000503:physiopathology*; D006624:Hippocampus / Q000187:drug effects / Q000293:injuries* / Q000503:physiopathology; D007051:Ibotenic Acid / Q000494:pharmacology; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D013216:Reflex, Startle / Q000187:drug effects / Q000502:physiology*; D055139:Sensory Gating / Q000187:drug effects / Q000502:physiology*
chemical_list: D007051:Ibotenic Acid